| All eyes | OAG | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|---|
 | n (%) | n (%) | OR | 95 % CI | p-value | OR | 95 % CI | p-value |
 | 26,316 (100 %) | 682 (2.6 %) |  |  |  |  |  |  |
Socio-demographic factors | Â | Â | Â | Â | Â | Â | Â | |
 Age (years) | (Min 40) |  | Reference |  |  | Reference |  |  |
 Increasing age | (Max 100) |  | 1.06 | 1.06–1.07 | <0.001 | 1.04 | 1.03–1.05 | <0.001 |
 Gender | Female | 328 (2.3) | Reference |  |  | Reference |  |  |
 | Male | 354 (2.9) | 1.29 | 1.06–1.57 | 0.01 | 1.23 | 0.94–1.61 | 0.13 |
 Ethnic group | Hausa | 113 (1.7) | Reference |  |  | Reference |  |  |
 | Yoruba | 150 (2.9) | 1.71 | 1.24–2.36 | 0.001 | 1.10 | 0.75–1.63 | 0.62 |
 | Igbo | 167 (4.5) | 2.70 | 1.98–3.68 | <0.001 | 1.73 | 1.18–2.56 | 0.01 |
 | Fulani | 31 (1.9) | 1.09 | 0.65–1.85 | 0.73 | 1.18 | 0.65–2.19 | 0.58 |
 | Kanuri | 20 (2.9) | 1.72 | 0.92–3.23 | 0.09 | 1.81 | 0.90–3.63 | 0.10 |
 | Tiv | 15 (2.2) | 1.30 | 0.64–2.62 | 0.47 | 1.03 | 0.42–2.52 | 0.96 |
 | Ijaw | 14 (2.9) | 1.69 | 0.86–3.35 | 0.13 | 1.51 | 0.50–4.60 | 0.47 |
 | Urhobo | 7 (1.5) | 0.85 | 0.32–2.23 | 0.74 | 0.69 | 0.24–1.97 | 0.48 |
 | Ibibio | 10 (2.4) | 1.43 | 0.62–3.27 | 0.40 | 1.29 | 0.58–2.89 | 0.53 |
 | Nupe | 9 (2.2) | 1.29 | 0.59–2.79 | 0.52 | 1.25 | 0.58–2.67 | 0.57 |
 | Others | 144 (2.4) | 1.38 | 1.01–1.90 | 0.05 | 1.13 | 0.75–1.70 | 0.57 |
 Literacy | Literate | 235 (2.0) | Reference |  |  | Reference |  |  |
 | Illiterate | 447 (3.0) | 1.50 | 1.22–1.84 | <0.001 | 1.06 | 0.79–1.42 | 0.70 |
 Place of residence | Rural | 527 (2.6) | Reference |  |  | Reference |  |  |
 | Urban | 155 (2.6) | 1.02 | 0.81–1.28 | 0.88 | 1.14 | 0.85–1.54 | 0.38 |
Biophysical factors | Â | Â | Â | Â | Â | Â | Â | |
 Hypertension | Normal | 454 (2.4) | Reference |  |  | NI |  |  |
 | Hypertension | 223 (3.2) | 1.38 | 1.12–1.70 | 0.002 |  |  |  |
 Blood pressure | Normal | 454 (2.4) | Reference |  |  | Reference |  |  |
 (severity of | stage 1 mild | 110 (2.7) | 1.15 | 0.88–1.51 | 0.31 | 0.87 | 0.57–1.33 | 0.52 |
 hypertension) | stage 2 moderate | 68 (3.7) | 1.61 | 1.16–2.24 | 0.01 | 1.05 | 0.58–1.90 | 0.87 |
 | stage 3 severe | 45 (4.4) | 1.91 | 1.27–2.88 | 0.002 | 1.05 | 0.45–2.45 | 0.90 |
 Systolic BP | (Min 60) |  | Reference |  |  | NI |  |  |
 | (Max 259) |  | 1.01 | 1.01–1.02 | <0.001 |  |  |  |
 Diastolic BP | (Min 35) |  | Reference |  |  | NI |  |  |
 | (Max 157) |  | 1.01 | 1.00–1.02 | 0.002 |  |  |  |
 RBGa | Normal | 141 (4.3) | Reference |  |  | NI |  |  |
 | Diabetes | 4 (4.1) | 0.94 | 0.33–2.67 | 0.91 |  |  |  |
 Body mass index | Normal | 406 (2.6) | Reference |  |  | Reference |  |  |
 (Categories) | Underweight | 116 (4.0) | 1.60 | 1.21–2.10 | 0.001 | 1.29 | 0.91–1.83 | 0.16 |
 | Overweight | 111 (2.2) | 0.85 | 0.65–1.12 | 0.26 | 0.82 | 0.58–1.17 | 0.27 |
 | Obese | 42 (1.9) | 0.75 | 0.50–1.12 | 0.16 | 1.18 | 0.71–1.96 | 0.52 |
Ocular factors | Â | Â | Â | Â | Â | Â | Â | Â |
 Axial length (mm) | (Min 18.4) |  | Reference |  |  | Reference |  |  |
 | (Max 30.0) |  | 1.14 | 1.03–1.26 | 0.01 | 0.99 | 0.89–1.10 | 0.88 |
I OP (mmHg) | (Min 5) |  | Reference |  |  | Reference |  |  |
 | (Max 50) |  | 1.21 | 1.18–1.23 | <0.001 | 1.22 | 1.18–1.25 | <0.001 |
 MOPP (mmHg) | (Min 6) |  | Reference |  |  | Reference |  |  |
 | (Max 115) |  | 0.96 | 0.95–0.97 | <0.001 | 1.01 | 0.99–1.03 | 0.40 |